ARCHIVES

IVAX And It’s Portfolio

This article is from The Cancer Letter archive.

Vol. 20 No. 49 | December 22, 1994

Download PDF Visit The Full Archive

Related Articles

Working Group To Review NCI Clinical Trials Programs

April 12, 1996

NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI

January 22, 1988

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006